Position in CABR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$544
New position
Shares Held
478
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 6 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $6,284,154 across 59 Drug Manufacturers - Specialty & Generic names. CABR ranks #57 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,684 | $998,578 | |
| 2 | ALKS |
Alkermes plc.
|
16,120 | $570,003 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,070 | $536,181 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,404 | $464,337 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
6,000 | $455,100 | |
| 6 | ZTS |
Zoetis Inc.
|
3,469 | $410,069 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16,717 | $347,044 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,887 | $227,404 |
All Filings in CABR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $544 | 478 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||